- Home
- OPK vs ASST Comparison
OPK vs ASST Comparison
Compare OPK & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPK | ASST |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2011 | 2022 |
Fundamental Metrics
Financial Performance| Metric | OPK | ASST |
|---|---|---|
| Price | $1.63 | $28.98 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $1.60 | ★ $23.50 |
| AVG Volume (30 Days) | 2.4M | ★ 8.8M |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.56 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $606,879,000.00 | $633,489.00 |
| Revenue This Year | N/A | $294.91 |
| Revenue Next Year | $4.24 | $12.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 128.67 |
| 52 Week Low | $0.98 | $0.49 |
| 52 Week High | $1.75 | $31.95 |
Technical Indicators
Market Signals| Indicator | OPK | ASST |
|---|---|---|
| Relative Strength Index (RSI) | 54.66 | 65.38 |
| Support Level | $1.46 | $14.32 |
| Resistance Level | $1.74 | $31.95 |
| Average True Range (ATR) | 0.06 | 1.78 |
| MACD | -0.01 | -0.41 |
| Stochastic Oscillator | 53.57 | 49.76 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About ASST Asset Entities Inc. Class B
Strive Inc is a structured finance company and institutional asset manager focused on disciplined capital allocation and long term value creation. The company has adopted bitcoin as its hurdle rate for capital deployment because of its fiduciary duty to maximize long-term value for stockholders, and compounding purchasing power over time. It operates in two reportable operating segments: the Asset Management segment, which provides investment advisory services and the Corporate & Other segment, which includes the company's bitcoin treasury operations. The majority of the revenue is derived from the Asset Management segment.